Loading insider details...
Beta
Latest Form 4 (Feb 4, 2026): Grant/Award of 204,000 MIST shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 4, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 204,000 | n/a |
| Jan 28, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 100,000 | n/a |
| Jul 15, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 50,000 | n/a |
| Jan 29, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 120,600 | n/a |
| Feb 17, 2023 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 130,000 | n/a |
| Mar 24, 2022 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 175,000 | n/a |
| Mar 27, 2021 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 240,000 | n/a |
| Jun 8, 2020 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 115,000 | n/a |
| Jan 24, 2020 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 82,000 | n/a |